Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.

The determination of a genetic basis for obsessive-compulsive disorder (OCD) depends on how phenotypic boundaries are defined. Although a hypothesis for serotonin dysfunction in OCD has been advanced, no genes specifically responsible for serotonin regulation have as yet been definitively related to the etiology of OCD. The phenotypic variability of OCD could be at the basis of the failure of molecular biology investigations to find any genes involved in the liability to the disorder. Obsessive and compulsive contents can aggregate in OCD patients differently; multifactorial description may therefore be able to account for OCD phenotypic variance. Using principal component analysis, we derived five factors from 13 main contents of the Yale-Brown Obsessive-Compulsive Scale (YBOCS), and considered them as quantitative phenotypes to evaluate their possible association with an insertion/deletion polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR). A trend toward positive association between the fifth factor, including counting and repeating rituals, and 5-HTTLPR was found. However, only considering the subgroup of patients with tic codiagnosis, we found a significantly higher score for the fifth factor for patients with L/L genotype with respect to L/S and S/S genotypes.

[1]  M. Cavallini,et al.  Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder , 2001, Journal of clinical psychopharmacology.

[2]  M. Cavallini,et al.  An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome , 2000, Psychiatry Research.

[3]  Y. Osher,et al.  Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs , 2000, Molecular Psychiatry.

[4]  R. Hoehn-Saric,et al.  A family study of obsessive compulsive disorder , 2001 .

[5]  W. Goodman,et al.  Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. , 1999, American journal of medical genetics.

[6]  S. Rauch,et al.  Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. , 1999, The American journal of psychiatry.

[7]  D. Murphy,et al.  Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder , 1999, Molecular Psychiatry.

[8]  M. Antony,et al.  Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. , 1999, Behaviour research and therapy.

[9]  E. Smeraldi,et al.  Complex segregation analysis for obsessive compulsive disorder and related disorders. , 1999, American journal of medical genetics.

[10]  C. McDougle,et al.  Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder , 1998, Molecular Psychiatry.

[11]  M. Cavallini,et al.  5HT2C CYS23/SER23 polymorphism is not associated with obsessive–compulsive disorder , 1998, Psychiatry Research.

[12]  K. Lesch,et al.  Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene , 1997, Molecular Psychiatry.

[13]  C. McDougle,et al.  Symptoms of obsessive-compulsive disorder. , 1997, The American journal of psychiatry.

[14]  M. Nöthen,et al.  Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. , 1997, Psychiatric genetics.

[15]  R. Murray,et al.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. , 1996, Molecular psychiatry.

[16]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[17]  D. Murphy,et al.  Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. , 1996, American journal of medical genetics.

[18]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[19]  W. Goodman,et al.  A family study of obsessive-compulsive disorder. , 1995, The American journal of psychiatry.

[20]  L. Baer Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. , 1994, The Journal of clinical psychiatry.

[21]  R. Joffe,et al.  Combined SSRI-moclobemide treatment of psychiatric illness. , 1994, The Journal of clinical psychiatry.

[22]  J. Terwilliger,et al.  A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. , 1992, Human heredity.

[23]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[24]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[25]  Wilfrid Joseph Dixon,et al.  Bmdp Statistical Software Manual: To Accompany the 1988 Software Release , 1988 .

[26]  P. McGuffin,et al.  Obsessive-Compulsive Neurosis: Two Identical Twin Pairs , 1980, British Journal of Psychiatry.